Investor FAQs

Show All
Show all

Founded in 2006, OptimizeRx is currently incorporated in Nevada.

OptimizeRx began trading on the public markets on November 28, 2007.

OptimizeRx trades under the ticker symbol OPRX on the Nasdaq Capital Market.

OptimizeRx’s fiscal financial reporting periods are based on the calendar year ending December 31. The company reports financial results on a quarterly basis for the three-month periods ending on March 31, June 30, September 30, and December 31.

OptimizeRx’s full year and fourth quarter results are typically announced in the first week of March. First quarter results are typically announced in the first week of May. Second quarter results are typically announced in the first week of August. Third quarter results are typically announced in the first week of November.

OptimizeRx’s common stock CUSIP is 68401U204.

OptimizeRx is a publicly traded company, currently trading on the Nasdaq Capital Market under the symbol OPRX. OptimizeRx’s stock can be purchased through your accredited stock broker, or through an on-line stock broker. Currently, there are no opportunities to buy stock directly from the company. Before making any investment decisions, you should read OptimizeRx’s SEC Filings, recent press releases, and risk factors.

Contact OptimizeRx’s stock transfer agent:

Computershare Limited
150 Royall Street, Suite 101
Canton, MA 02021
(781) 575-3100
https://www.computershare.com
web.queries@computershare.com

UHY LLP
12900 Hall Road, Suite 500
Sterling Heights, MI 48313

OptimizeRx is headquartered in Waltham, MA at the following address: 260 Charles Street Suite 302 
Waltham, MA 02453

OptimizeRx has not historically declared a cash dividend, and has no plans to do so in the foreseeable future.

OptimizeRx’s Annual Report, 10-Qs, 10-Ks, 8-Ks and other SEC filings are available on the investor relations website under SEC Filings.

OptimizeRx encourages environmental conservatism. An online version of OptimizeRx’s Annual Report, 10-Qs, 10-Ks, 8-Ks and other SEC filings are available on the investor relations website under SEC Filings.

OptimizeRx Contact:


Andy D’Silva, SVP of Corporate Finance
adsilva@optimizerx.com

Sandya von der Weid
LifeSci Advisors, LLC
svonderweid@lifesciadvisors.com